Depending on the plan we build together, that can mean:

For a long time, treating glaucoma meant climbing a ladder one rung at a time: one drop to start, additional drops layered on as the years passed, and surgery held in reserve until the disease had already progressed significantly. There's nothing wrong with drops, and they remain a valuable part of care. What's changed is our strategy. Interventional glaucoma moves the more definitive tools earlier in the process, so we're not simply reacting to progression after it happens.
Think of it less as a single operation and more as a philosophy of care. It leans on early, low-impact procedures and long-acting medication delivery instead of asking patients to shoulder a drop regimen indefinitely. That preference is grounded in what the research keeps showing us: the sooner and more steadily we lower intraocular pressure, the better a patient's odds of holding on to their vision.
Prescription drops are where most glaucoma treatment begins, and for a good number of patients, they do exactly what they're supposed to. The difficulty isn't the medication itself; it's what a lifetime of using it correctly demands.
Staying on Schedule: Getting a drop into the eye on schedule, every single day, for the rest of your life, turns out to be a tall order. Between busy days, multi-bottle routines, an ordinary slip of memory, and the simple physical challenge of aiming a drop, doses get missed more often than most patients would guess.
Risks of Missed Doses: A missed dose isn't a minor thing. Pressure that drifts upward, even briefly, gives glaucoma room to keep damaging the optic nerve, usually without any symptom to warn you it's happening.
Unpleasant Side Effects: Drops can leave the eyes stinging, red, dry, or briefly blurred, and over time they can change the look of the eyes and lashes.
Costs Add Up: The costs also quietly accumulate, and across decades of treatment they can reach a figure few people anticipate at the outset.
None of this means drops are the wrong choice for everyone. But when they become a burden, stop working well, or don't fit into a patient's life, interventional glaucoma offers a promising alternative.
You may be a good candidate for interventional glaucoma treatment if:
The only way to know for certain is a comprehensive evaluation with one of our eye doctors. Once we've examined your eyes, we'll talk through the choices in plain terms and point you toward the plan that fits your eyes, your daily life, and your goals.

Our glaucoma physicians will be with you through every stage, from that first evaluation through treatment and ongoing follow-up.
The traditional route is essentially a waiting game, adding medications one by one and holding surgery back until the disease insists on it. An interventional approach reorders those priorities, putting minimally invasive procedures and in-eye medication delivery on the table much earlier. The payoff we're after is threefold: guarding the optic nerve sooner, keeping pressure steadier over the long run, and lifting the daily treatment burden off the patient.
Sometimes, though it depends on your chosen treatment and your individual case. Plenty of patients come away needing far fewer drops than before, and a portion can stop altogether. Rather than promise a specific outcome, we'll give you a candid read at your evaluation on what's realistic for your stage of glaucoma and the option you choose.
While there are risks with any procedure, the interventional treatments we use, particularly the MIGS options, were designed from the start to be less invasive than conventional glaucoma surgery: small or no incisions, cooperation with the eye's own drainage, and a recovery that rarely disrupts daily life for long. Your physician will walk you through the specific pros and cons for your case before anything is scheduled.
Often, yes, and it's one of the real advantages of doing this early. Several interventional treatments can be performed in the same session as cataract surgery, so both conditions get handled in a single visit to the OR. Whether that combination suits you depends on your overall eye health, which your surgeon will assess.

Glaucoma is a lifelong diagnosis, but it doesn't have to run your life. Treating it early and actively lets our team get your pressure under control before the disease gains ground, preserve more of your vision, and put together a plan that bends to your routine instead of the reverse.
Raleigh Ophthalmology is proud to give patients in Raleigh, North Raleigh, and Clayton a modern answer to a condition that deserves one.
